Events & Presentations

Upcoming Webcasts

No webcasts scheduled. Check back soon.

Webcast Archive

  • AMT-130 Huntington’s Disease Program Update

    View Webcast
  • uniQure AMT-130 Program Update
    8:30 a.m.

    View Webcast
  • Guggenheim Genomic Medicines & Rare Disease Day
    8:00 a.m. ET / 2:00 p.m. CET

    View Webcast

Investor Presentations

  • uniQure Corporate Presentation – August 2022

    View Presentation
  • AMT-130 12-Month Low-Dose Cohort Update – Investor Webcast Presentation

    View Presentation
  • EAHAD 2022 – Final Analysis from the Pivotal Phase 3 HOPE-B Gene Therapy Trial: Stable Steady-State Efficacy and Safety of Etranacogene Dezaparvovec in Adults with Severe or Moderately Severe Hemophilia B

    View Presentation
  • ISTH 2021 – Clinical Outcomes in Adults with Hemophilia B With Pre-existing Neutralizing Antibodies to AAV5: 6 Month Data from the HOPE-B Trial

    View Presentation
  • Gene Therapy Information

    View Presentation
uniQure Logo Twitter Icon LinkedIn Icon YouTube Icon Twitter Icon Arrow Slideshow Next Button